Metraipolis › archive › dc_fb2c7cb56f07

Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome — Europe PMC PMID:41584355

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41584355
DOI
10.1016/j.apsb.2025.10.048
License (as archived)
solo-consultazione
Archived
2026-11-08T19:39:35.801Z
SHA-256 of the archived text
c95185a4f7313047453dabbd9180dc02fdff71dc4c121700fde6460cac6b8707
Stable URL of this page
https://metraipolis.com/documento/dc_fb2c7cb56f07

How to cite

Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome — Europe PMC PMID:41584355 — Europe PMC (en), https://europepmc.org/article/MED/41584355 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb2c7cb56f07 (Metraipolis archive dc_fb2c7cb56f07, sha256 c95185a4f7313047453dabbd9180dc02fdff71dc4c121700fde6460cac6b8707)
BibTeX
@misc{dcfb2c7cb56f07,
  title = {Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome — Europe PMC PMID:41584355},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41584355},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb2c7cb56f07; sha256 c95185a4f7313047453dabbd9180dc02fdff71dc4c121700fde6460cac6b8707},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584355. Agents can read the archived copy with the MCP tool read_document.